期刊文献+

慢性阻塞性肺疾病患者继发肺部真菌感染50例临床分析 被引量:1

Chronicity blocking lung disease patient to continue sends the lungs fungus to infect 50 examples clinically to analyze
原文传递
导出
摘要 目的:探讨慢性阻塞性肺疾病(COPD)继发真菌感染的诱因,临床特点及应对策略。方法:诊断为COPD继发肺部真菌感染患者50例,对其使用抗生素,激素情况及年龄,病程及影像学资料进行分析。结果:50例COPD患者多见于老年人,与患者的原发病,长期使用抗生素、糖皮质激素、营养状况差、反复住院及有创的检查等有关。结论:真菌感染多见,临床医师必须提高警惕,在选择抗生素要针对性强、抗菌谱窄、减少真菌感染的机会。 Objective:Discussion chronicity blocking lung disease (COPD) continues sends the fungus infection the cause, the clin- ical characteristic and should fo the .strategy. Methods: The diagnosis is COPD continues sends the lungs fungus to infect the patient 50 examples, to its use antibiotic, the hormone situation and the age, the course of an illness and the phantom study material carries on the analysis. Results:50 example COPD patient sees in the senior citizen, with patient's the primary affection, the long--term use antibiotic,the sugar eortical hormone,the nutrition condition difference,is hospitalized repeatedly the inspection which and has creates and so on related. Conclusion the fungus infection sees, clinician must enhance vigilance, wants strong, the antibacterial spectrum pointed in the choice antibiotic narrow,the reduced fungus infection opportunity.
作者 毛苏萍
出处 《按摩与康复医学》 2010年第17期69-70,共2页 Chinese Manipulation and Rehabilitation Medicine
关键词 慢性阻塞性肺疾 肺部真菌感染 临床分析 Chronic blocking lung illness Lungs fungus infection Clinical analysis
  • 相关文献

参考文献4

二级参考文献20

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2何礼贤,邵长周.侵袭性肺曲霉病的分级诊断和治疗[J].中华结核和呼吸杂志,2006,29(5):297-298. 被引量:52
  • 3Loeffler J,Stevens DA. Antifungal drug resistance. Clin Infect Dis,2003,36 (Suppl 1):S31-S41.
  • 4Greer ND. Voficonazole: the newest triazole antifungal agent. Proc(Bayl Univ Med Cent) ,2003,16:241-248.
  • 5Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis,2004,38: 161-189.
  • 6Boyd AE, Modi S, Howard S.I, et al. Adverse reactions to voriconazole. Clin Infect Dis,2004,39:1241-1244.
  • 7Deresinski SC,Stevens DA. Caspofungin. Clin Infect Dis,2003,36:1445-1457.
  • 8Pfaller MA, Boyken L, Hollis RJ, et al. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole. J Clin Microbio1,2005,43:5425-5427.
  • 9Hope WW, Warn PA, Sharp A, et al. Surface response modeling to examine the combination of amphotericin B deoxycholate and 5-fluorocytosine for treatment of invasive candidiasis. J Infect Dis,2005,192:673-680.
  • 10Ostrosky-Zeichner L. Novel approaches to antifungal prophylaxis.Expert Opin Investig Drugs,2004,13:665-672.

共引文献1856

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部